Events Partner Content 4th Microbiome Movement - Drug Development Europe Summit Microbiome Movement - Drug Development Europe Summit
News Roche taps Simcere for autoimmune trispecific for $1.53bn Roche is paying $75m upfront for a trispecific drug developed by China's Simcere Zaiming for B-cell-mediated autoimmune disorders and blood cancers.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
